Enhanced fasting and post-prandial plasma bile acid responses after Roux-en-Y gastric bypass surgery

Scandinavian Journal of Gastroenterology

Volumn 48, Issue 11, 2013, Pages 1257-1264

  Werling, Malin ^a   Vincent, Royce P ^b   Cross, Gemma F ^b   Marschall, Hanns Ulrich ^c   Fändriks, Lars ^a   Lönroth, Hans ^a   Taylor, David R ^b   Alaghband Zadeh, Jamshid ^b   Olbers, Torsten ^a   Le Roux, Carel W ^a,b,d  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^b KING'S COLLEGE HOSPITAL NHS FOUNDATION TRUST   (United Kingdom)

^c UNIVERSITY OF GOTHENBURG   (Sweden)

^d UNIVERSITY COLLEGE DUBLIN   (Ireland)

Author keywords

Bile acids; Obesity; Roux en Y bypass

Indexed keywords

BILE ACID; C REACTIVE PROTEIN; GASTROINTESTINAL HORMONE; GLUCAGON LIKE PEPTIDE 1; GLUCOSE; GLYCINE; INSULIN; TYROSINE;

ADULT; AREA UNDER THE CURVE; ARTICLE; BILE ACID BLOOD LEVEL; BLOOD SAMPLING; BODY MASS; DIET RESTRICTION; FEMALE; GLUCAGON BLOOD LEVEL; GLUCOSE BLOOD LEVEL; HOMEOSTASIS; HUMAN; INSULIN BLOOD LEVEL; MAJOR CLINICAL STUDY; POSTPRANDIAL STATE; PRIORITY JOURNAL; PROSPECTIVE STUDY; ROUX EN Y GASTRIC BYPASS SURGERY; STOMACH BYPASS; WEIGHT REDUCTION;

ADULT; BILE; BLOOD GLUCOSE; BODY MASS INDEX; C-REACTIVE PROTEIN; COHORT STUDIES; FASTING; FEMALE; GASTRIC BYPASS; GLUCAGON-LIKE PEPTIDE 1; HUMANS; INSULIN; INSULIN RESISTANCE; MALE; MIDDLE AGED; OBESITY; POSTPRANDIAL PERIOD; TIME FACTORS; WEIGHT LOSS;

EID: 84885923467     PISSN: 00365521     EISSN: 15027708     Source Type: Journal    
DOI: 10.3109/00365521.2013.833647     Document Type: Article

References (43)

1. Sjöström L, Lindroos AK, Peltonen M, et al. Swedish Obese Subjects Study Scientific Group. Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery. N Engl J Med 2004;351:2683-93.
2. Falkén Y, Hellström PM, Holst JJ, et al. Changes in glucose homeostasis after Roux-en-Y gastric bypass surgery for obesity at day three, two months, and one year after surgery: Role of gut peptides. J Clin Endocrinol Metab 2011;96:2227-35.
3. Buse JB, Caprio S, Cefalu WT, et al. How do we define cure of diabetes?. Diabetes Care 2009;32:2133-5.
4. Pournaras DJ, Aasheim ET, Søvik TT, et al. Effect of the definition of type II diabetes remission in the evaluation of bariatric surgery for metabolic disorders. Br J Surg 2012;99: 100-3.
5. Schauer PR, Kashyap SR, Wolski K, et al. Bariatric surgery versus intensive medical therapy in obese patients with diabetes. N Engl J Med 2012;366:1567-76.
6. Pournaras DJ, Osborne A, Hawkins SC, et al. 2010;Remission of type 2 diabetes after gastric bypass and banding: Mechanisms and 2 year outcomes. Ann Surg 2010;252:966-71.
7. Pournaras DJ, Glicksman C, Vincent RP, et al. The role of bile after Roux-en-Y gastric bypass in promoting weight loss and improving glycaemic control. Endocrinology 2012;153: 3613-19.
8. Kohli R, Bradley D, Setchell KD, et al. Weight Loss Induced by Roux-en-Y Gastric Bypass But Not Laparoscopic Adjustable Gastric Banding Increases Circulating Bile Acids. J Clin Endocrinol Metab 2013;98:708-12.
9. le Roux CW, Aylwin SJ, Batterham RL, et al. Gut hormone profiles following bariatric surgery favor an anorectic state, facilitate weight loss, and improve metabolic parameters. Ann Surg 2006;43:108-14.
10. Angelin B, Björkhem I, Einarsson K, et al. Hepatic uptake of bile acids in man. Fasting and postprandial concentrations of individual bile acids in portal venous and systemic blood serum. J Clin Invest 1982;70:724-31.
11. Lefebvre P, Cariou B, Lien F, et al. Role of bile acids and bile acid receptors in metabolic regulation. Physiol Rev 2009;89: 147-91.
12. Prawitt L, Staels B. Bile acid sequestrants: Glucose-lowering mechanisms. Metab Syndr Relat Disord 2010;8:3-8.
13. Garg A, Grundy SM. Cholestyramine therapy for dyslipidemia in non-insulin-dependent diabetes mellitus. A shortterm, double-blind, crossover trial. Ann Intern Med 1994; 121:416-22.
14. Adrian TE, Gariballa S, Parekh KA, et al. Rectal taurocholate increases L cell and insulin secretion, and decreases blood glucose and food intake in obese type 2 diabetic volunteers. Diabetologia 2012;55:2343-7.
15. Knop FK. Bile-induced secretion of glucagon-like peptide-1: Pathophysiological implications in type 2 diabetes?. Am J Physiol Endocrinol Metab 2010;299:10-13.
16. Song KH, Li T, Owsley E, et al. Bile acids activate fibroblast growth factor 19 signaling in human hepatocytes to inhibit cholesterol 7alpha-hydroxylase gene expression. Hepatology 2009;49:297-305.
17. Park WH, Pak YK. Insulin-dependent suppression of cholesterol 7alpha-hydroxylase is a possible link between glucose and cholesterol metabolism. Exp Mol Med 2011;43:571-9.
18. VanPatten S, Karkanias GB, Rossetti L, et al. Intracerebroventricular leptin regulates hepatic cholesterol metabolism. Biochem J 2004;379:229-33.
19. Li T, Jahan A, Chiang JY. Bile acids and cytokines inhibit the human cholesterol 7 alpha-hydroxylase gene via the JNK/c-jun pathway in human liver cells. Hepatology 2006;43: 1202-10.
20. Glicksman C, Pournaras DJ, Wright M, et al. Post-prandial plasma bile acid responses in normal weight and obese subjects. Ann Clin Biochem 2010;47:482-4.
21. Simonen M, Dali-Youcef N, Kaminska D, et al. Conjugated bile acids associate with altered rates of glucose and lipid oxidation after Roux-en-Y gastric bypass. Obes Surg 2012; 22:1473-80.
22. Patti ME, Houten SM, Bianco AC, et al. Serum bile acids are higher in humans with prior gastric bypass: Potential contribution to improved glucose and lipid metabolism. Obesity (Silver Spring) 2009;17:1671-7.
23. Nakatani H, Kasama K, Oshiro T, et al. Serum bile acid along with plasma incretins and serum high-molecular weight adiponectin levels are increased after bariatric surgery. Metabolism 2009;58:1400-7.
24. Tagliacozzi D, Mozzi AF, Casetta B, et al. Quantitative analysis of bile acids in human plasma by liquid chromatography-electrospray tandem mass spectrometry: A simple and rapid one-step method. Clin Chem Lab Med 2003;41:1633-41.
25. Kreymann B, Williams G, Ghatei MA, et al. Glucagon-like pretide-1 7-36: A physiological incretin in man. Lancet 1987; 2:300-4.
26. Savage AP, Adrian TE, Carolan et al. Effects of peptide YY (PYY) on mouth to caecum intestinal transit time and on the rate of gastric emptying in healthy volunteers. Gut 1987;28: 166-70.
27. Harris K, Kassis A, Major G, et al. Is the gut microbiota a new factor contributing to obesity and its metabolic disorders?. J Obes 2012;2012:879151.
28. Bigornia SJ, Farb MG, Mott MM, et al. Relation of depotspecific adipose inflammation to insulin resistance in human obesity. Nutr Diabetes 2012;2:30.
29. Harman-Boehm I, Blüher M, Redel H, et al. Macrophage infiltration into omental versus subcutaneous fat across different populations: Effect of regional adiposity and the comorbidities of obesity. J Clin Endocrinol Metab 2007; 92:2240-7.
30. Schipper HS, Prakken B, Kalkhoven E, et al. Adipose tissueresident immune cells: Key players in immunometabolism. Trends Endocrinol Metab 2012;23:407-15.
31. Monte SV, Caruana JA, Ghanim H, et al. Reduction in endotoxemia, oxidative and inflammatory stress, and insulin resistance after Roux-en-Y gastric bypass surgery in patients with morbid obesity and type 2 diabetes mellitus. Surgery 2012;151:587-93.
32. Cani PD, Osto M, Geurts L, et al. Involvement of gut microbiota in the development of low-grade inflammation and type 2 diabetes associated with obesity. Gut Microbes 2012;3:279-88.
33. Li JV, Ashrafian H, Bueter et al. Metabolic surgery profoundly influences gut microbial-host metabolic cross-Talk. Gut 2011;60:1214-23.
34. Thomas C, Auwerx J, Schoonjan K. Bile acids and the membrane bile acid receptor TGR5-connecting nutrition and metabolism. Thyroid 2008;18:167-74.
35. Kumar DP, Rajagopal S, Mahavadi S, et al. Activation of transmembrane bile acid receptor TGR5 stimulates insulin secretion in pancreatic b cells. BiochemBiophys Res Commun 2012;427:600-5.
36. Düfer M, Hörth K, Wagner R, et al. Bile acids acutely stimulate insulin secretion of mouse b-cells via farnesoid X receptor activation and K(ATP) channel inhibition. Diabetes 2012;61:1479-89.
37. Bile acids and gut peptide secretion after bariatric surgery - A 1-year prospective randomized pilot trial. Obesity (Silver Spring) 2013
38. Steinert RE, Peterli R, Keller S, et al. Bile acids and gut peptide secretion after bariatric surgery - A 1-year prospective randomized pilot trial. Obesity (Silver Spring) 2013;doi: 10.1002/oby.20522; Epub ahead of print. [38] Kohli R, Setchell KDR, Kirby M, et al. A Surgical Model in Male Obese Rats Uncovers Protective Effects of Bile Acids Post-Bariatric Surgery. Endocrinology 2013;154:2341-51.
39. Gerhard GS, Styer AM, Wood GC, et al. A Role for Fibroblast Growth Factor 19 and Bile Acids in Diabetes Remission After Roux-en-Y Gastric Bypass. Diabetes Care 2013;36: 1859-64.
40. Russell DW. The enzymes, regulation, and genetics of bile acid synthesis. Annu Rev Biochem 2003;72:137-74.
41. Falany CN, Johnson MR, Barnes S, et al. Glycine and taurine conjugation of bile acids by a single enzyme. J Biol Chem 1994;269:19375-9.
42. Beckman LM, Beckman TR, Sibley SD, et al. Changes in gastrointestinal hormones and leptin after Roux-en-Y gastric bypass surgery. JPEN J Parenter Enteral Nutr 2011;35: 169-80.
43. Schreuder TC, Marsman HA, Lenicek M, et al. The hepatic response to FGF19 is impaired in patients with nonalcoholic fatty liver disease and insulin resistance. Am J Physiol Gastrointest Liver Physiol 2010;298:440-5.